The stock's fall snapped a four-day winning streak.

Among the safety stocks discussed by Cramer during the episode on May 14, Bristol-Myers Squibb Company (NYSE:BMY) was first ...

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology ...

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Bernstein 41 st Annual Strategic ...

This was the stock's fourth consecutive day of gains.

Bristol-Myers Squibb (NYSE:BMY) recently received European Commission approval for its Opdivo regimen in treating resectable ...

Roche, along with Bristol Myers Squibb, Novo Nordisk, AbbVie, Eli Lilly and others, is making inroads into molecular glues to ...

BMSCH opens a Same Day Services center for kids needing infusion therapies, backed by a $2.5M gift from the Bristol Myers ...

The settlement divides the $700 million payment equally between pharmaceutical giants Bristol Myers Squibb and Sanofi.